Recombinant Human ESRP1 Protein, N-His from ProteoGenix; catalogue ARO-P11198; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human ESRP1 Protein, also known as Epithelial Splicing Regulatory Protein 1, is a type of recombinant protein that plays a crucial role in regulating alternative splicing of pre-mRNA transcripts. This protein is encoded by the ESRP1 gene and is essential for the proper functioning of the human body.
Recombinant Human ESRP1 Protein is a 54 kDa protein consisting of 475 amino acids. It belongs to the RNA-binding motif (RRM) family and contains two RNA recognition motifs (RRMs) at its N-terminus. These RRMs are responsible for the binding of ESRP1 to specific RNA sequences, thereby regulating alternative splicing.
The C-terminus of Recombinant Human ESRP1 Protein contains a proline-rich region, which is involved in protein-protein interactions. This region interacts with other splicing factors and regulates the activity of ESRP1 in alternative splicing.
The main activity of Recombinant Human ESRP1 Protein is the regulation of alternative splicing. Alternative splicing is a process in which different exons from a single gene are combined in different ways to produce multiple protein isoforms. This process is crucial for the diversity of proteins in the human body and plays a significant role in various physiological processes.
ESRP1 protein acts as a splicing factor and binds to specific RNA sequences in pre-mRNA transcripts, thereby influencing the splicing process. It promotes the inclusion of specific exons and the exclusion of others, resulting in the production of different protein isoforms. This activity of ESRP1 is essential for the proper functioning of various tissues, including the epithelial cells of the skin, lungs, and intestines.
The application of Recombinant Human ESRP1 Protein is primarily focused on its role in regulating alternative splicing. This protein has been found to be dysregulated in various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Therefore, it has potential therapeutic applications in these conditions.
In cancer, ESRP1 has been shown to regulate the splicing of genes involved in cell proliferation, invasion, and metastasis. Its dysregulation has been linked to the development and progression of various types of cancer, including breast, lung, and colon cancer. Recombinant Human ESRP1 Protein can be used to study the role of this protein in cancer and develop targeted therapies to modulate its activity.
In neurodegenerative disorders, ESRP1 has been found to regulate the splicing of genes involved in neuronal function and survival. Its dysregulation has been linked to conditions such as Alzheimer’s disease and Parkinson’s disease. Recombinant Human ESRP1 Protein can be used to study the role of this protein in neurodegenerative disorders and develop potential therapeutic interventions.
Moreover, ESRP1 has also been found to play a role in autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease. Its dysregulation has been linked to the abnormal production of cytokines and inflammatory mediators. Recombinant Human ESRP1 Protein can be used to study the role of this protein in autoimmune diseases and develop targeted therapies to modulate its activity.
In conclusion, Recombinant Human ESRP1 Protein is a crucial protein involved in the regulation of alternative splicing. Its structure, activity, and application have been extensively studied and have shown its potential as a therapeutic target in various diseases. Further research on this protein may lead to the development of novel treatments for cancer, neurodegenerative disorders, and autoimmune diseases.
ProteoGenix catalogue number ARO-P11198. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 23.55 kDa; Fragment: Met1-Ser193; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
